Melatonin shortens the survival rate of Ehrlich ascites-inoculated mice

Neuro Endocrinol Lett. 2001 Dec;22(6):432-4.

Abstract

OBJECTIVES Pineal gland may have a role in organism's protection against cancer. Melatonin as well as still unidentified low-weight molecular pineal substance(s) have been reported to have growth inhibitory effect on different tumor cells. We tested the influence of melatonin and of a bovine pineal extract on the survival rate of AKR mice inoculated with Ehrlich ascites. The tumor is known to have an accelerated development after pinealectomy.

Material and methods: Male AKR mice, kept under a 14/10 hours - Light /Dark cycle, were inoculated intraperitoneally (i.p.) with 1.5x 10(6) Ehrlich ascites cells. On day three after inoculation the animals were divided in three groups (n=10). Each animal received i.p. daily (20.00H), until their death, 250 microl of solution containing melatonin (250 microg), pineal extract (equivalent of 1 bovine pineal gland) or saline.

Results: The average survival rate of the animals treated with melatonin was shorter (14.8+/-2.23 days) compared to control animals (21.9+/-2.21 days)(p=0.01). The animals treated with the pineal extract had a longer survival rate (22.6 +/- 1.8 days) but not statistically significant. The pineal extract was not available for testing at higher doses.

Conclusion: In our model, melatonin had a deleterious effect on the survival rate raising the question whether it is correct to assume that the hormone shows lack of adverse reactions.

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Carcinoma, Ehrlich Tumor / drug therapy*
  • Carcinoma, Ehrlich Tumor / mortality*
  • Cattle
  • Cell Extracts / pharmacology
  • Male
  • Melatonin / pharmacology*
  • Mice
  • Mice, Inbred AKR
  • Neoplasm Transplantation
  • Pineal Gland / physiology
  • Survival Rate

Substances

  • Antioxidants
  • Cell Extracts
  • Melatonin